HF
BCAB

HRT Financial’s BIOATLA INC BCAB Stock Holding History

HRT Financial’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54K Buy
+13,276
New +$56.3K ﹤0.01% 3751
2026
Q1 		– Sell
-1,095
Closed -$31K – 3796
2025
Q4 		$31K Buy
1,095
+228
+26% +$8.94K ﹤0.01% 2934
2025
Q3 		$29K Buy
867
+452
+109% +$10.4K ﹤0.01% 2660
2025
Q2 		$8K Buy
+415
New +$8.41K ﹤0.01% 2461
2025
Q1 		– Sell
-250
Closed -$7K – 2530
2024
Q4 		$7K Buy
+250
New +$21K ﹤0.01% 2305
2024
Q3 		– Sell
-1,256
Closed -$86K – 2417
2024
Q2 		$86K Buy
+1,256
New +$149K ﹤0.01% 1779
2022
Q3 		– Sell
-2,932
Closed -$417K – 2801
2022
Q2 		$417K Sell
2,932
-1,044
-26% -$166K ﹤0.01% 1800
2022
Q1 		$994K Buy
+3,976
New +$1.66M 0.01% 1040

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's BCAB Position: Q2 2026 in Review

HRT Financial opened a new position in BIOATLA INC (BCAB) in Q2 2026: 13,276 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #3751 among its holdings. This is a return to the name: HRT Financial previously reported a position in BCAB as recently as Q4 2025.

HRT Financial first reported a position in BCAB in Q1 2022 and has held it in 8 quarters since. The position peaked at $994K in Q1 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • HRT Financial held 13,276 shares of BIOATLA INC worth $54K as of Q2 2026.
  • BIOATLA INC was a new HRT Financial position in Q2 2026.
  • BIOATLA INC made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3751 holding.
  • HRT Financial first reported a position in BIOATLA INC in Q1 2022 and has held it in 8 quarters since.
  • HRT Financial's BIOATLA INC position peaked at $994K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.